Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 16

1.

Qualitative Research on Fatigue Associated with Depression: Content Validity of the Fatigue Associated with Depression Questionnaire (FAsD-V2).

Matza LS, Murray LT, Phillips GA, Konechnik TJ, Dennehy EB, Bush EN, Revicki DA.

Patient. 2015 Oct;8(5):433-43. doi: 10.1007/s40271-014-0107-7.

2.

Telomere shortening in leukocyte subpopulations in depression.

Karabatsiakis A, Kolassa IT, Kolassa S, Rudolph KL, Dietrich DE.

BMC Psychiatry. 2014 Jul 5;14:192. doi: 10.1186/1471-244X-14-192.

3.

Evidence for the management of adolescent depression.

Lewandowski RE, Acri MC, Hoagwood KE, Olfson M, Clarke G, Gardner W, Scholle SH, Byron S, Kelleher K, Pincus HA, Frank S, Horwitz SM.

Pediatrics. 2013 Oct;132(4):e996-e1009. doi: 10.1542/peds.2013-0600. Epub 2013 Sep 16. Review.

4.

The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition.

Matza LS, Wyrwich KW, Phillips GA, Murray LT, Malley KG, Revicki DA.

Qual Life Res. 2013 Mar;22(2):351-60. doi: 10.1007/s11136-012-0142-6. Epub 2012 Mar 9.

5.

Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication.

McClintock SM, Husain MM, Wisniewski SR, Nierenberg AA, Stewart JW, Trivedi MH, Cook I, Morris D, Warden D, Rush AJ.

J Clin Psychopharmacol. 2011 Apr;31(2):180-6. doi: 10.1097/JCP.0b013e31820ebd2c. Erratum in: J Clin Psychopharmacol. 2013 Dec;33(6):765.

6.

Parent Depression and Child Anxiety: An Overview of the Literature with Clinical Implications.

Colletti CJ, Forehand R, Garai E, Rakow A, McKee L, Fear JM, Compas BE.

Child Youth Care Forum. 2009 Jun 1;38(3):151-160.

7.

Adapted behavior therapy for persistently depressed primary care patients: an open trial.

Uebelacker LA, Weisberg RB, Haggarty R, Miller IW.

Behav Modif. 2009 May;33(3):374-95. doi: 10.1177/0145445509331924. Epub 2009 Mar 11.

8.

Psychosocial determinants of recovery in depression.

Fava GA, Visani D.

Dialogues Clin Neurosci. 2008;10(4):461-72. Review.

9.

Medicine Cabinet: Drug treatment of depression.

Martensson B, Spigset O.

West J Med. 1999 Aug;171(2):102-5. No abstract available.

10.

Venlafaxine extended release (XR) in the treatment of panic disorder.

Kjernisted K, McIntosh D.

Ther Clin Risk Manag. 2007 Mar;3(1):59-69.

11.

Depression and sleep: pathophysiology and treatment.

Thase ME.

Dialogues Clin Neurosci. 2006;8(2):217-26. Review.

12.

Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale.

McIntyre RS, Konarski JZ, Mancini DA, Fulton KA, Parikh SV, Grigoriadis S, Grupp LA, Bakish D, Filteau MJ, Gorman C, Nemeroff CB, Kennedy SH.

CMAJ. 2005 Nov 22;173(11):1327-34. Erratum in: CMAJ. 2006 Jan 17;174(2):207.

13.

From the Bench to the Trench: A Comparison of Sertraline Treatment of Major Depression in Clinical and Research Patient Samples.

Lydiard RB, Perera P, Batzar E, Clary CM.

Prim Care Companion J Clin Psychiatry. 1999 Oct;1(5):154-162.

14.

Steps Following Attainment of Remission: Discontinuation of Antidepressant Therapy.

Shelton RC.

Prim Care Companion J Clin Psychiatry. 2001 Aug;3(4):168-174.

15.

Pharmacotherapy to sustain the fully remitted state.

Kennedy S, McIntyre R, Fallu A, Lam R.

J Psychiatry Neurosci. 2002 Jul;27(4):269-80. Review.

16.

Fortnightly review: drug treatment of depression.

Spigset O, MÃ¥rtensson B.

BMJ. 1999 May 1;318(7192):1188-91. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk